The estimated Net Worth of Shannon Hall is at least $373 Thousand dollars as of 1 September 2024. Ms. Hall owns over 1,074 units of Mesa Laboratories stock worth over $333,002 and over the last 4 years she sold MLAB stock worth over $40,245. In addition, she makes $0 as Director at Mesa Laboratories.
Sign up
Ms. Hall MLAB stock SEC Form 4 insiders trading
Shannon has made over 7 trades of the Mesa Laboratories stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 1,074 units of MLAB stock worth $128,418 on 1 September 2024.
The largest trade she's ever made was exercising 1,074 units of Mesa Laboratories stock on 1 September 2024 worth over $128,418. On average, Shannon trades about 270 units every 115 days since 2020. As of 1 September 2024 she still owns at least 2,785 units of Mesa Laboratories stock.
You can see the complete history of Ms. Hall stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Shannon Hall biography
Shannon Hall serves as Director of the Company. Shannon Hall was appointed as a director on May 11, 2020. Ms. Hall currently serves on the Board of one privately-held company. Additionally, she works as an investor and advisor to multiple early stage startups, primarily in the life sciences industry and is co-founder of Pow.bio. For 25 years, she worked at Bio-Rad Laboratories in progressive roles, including over ten years in executive leadership roles. She led core businesses at Bio-Rad Laboratories, creating effective leadership teams and improving sales growth and margins in her organizations. Ms. Hall received a Bachelor of Arts in Biology from the College of Saint Benedict.
How old is Shannon Hall?
Shannon Hall is 51, she's been the Director of Mesa Laboratories since 2020. There are 11 older and 1 younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories, Inc. is David Kelly, 78, who is the Independent Director.
What's Shannon Hall's mailing address?
Shannon's mailing address filed with the SEC is Alfred Nobel Drive, Hercules, Contra Costa County, California, 94547, United States of America.
Insiders trading at Mesa Laboratories
Over the last 21 years, insiders at Mesa Laboratories have traded over $50,273,983 worth of Mesa Laboratories stock and bought 209,660 units worth $5,099,819 . The most active insiders traders include Mark Christopher Capone, R Tony Tripeny, and John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of $430,930. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth $394,701.
What does Mesa Laboratories do?
mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers
What does Mesa Laboratories's logo look like?
Complete history of Ms. Hall stock trades at Mesa Laboratories
Mesa Laboratories executives and stock owners
Mesa Laboratories executives and other stock owners filed with the SEC include:
-
Gary Owens,
President, Chief Executive Officer, Director -
John Sakys,
Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary -
Greg DiNoia,
Senior Vice President - Commercial Operations -
Gary M. Owens,
CEO, Pres & Director -
Brian Archbold,
Senior Vice President - Continuous Improvement -
Brian David Archbold,
Sr. VP of Continuous Improvement -
John V. Sakys,
CFO & Chief Accounting Officer -
Gregory T. DiNoia,
Sr. VP of Commercial Operations -
John Sullivan,
Chairman of the Board -
John Schmieder,
Independent Director -
David Kelly,
Independent Director -
Evan Guillemin,
Independent Director -
Jennifer Alltoft,
Independent Director -
Shannon Hall,
Director -
Peter M. Dansky,
Pres of Clinical Genomics -
Garrett Krushefski,
Sr. VP of Operations -
Bryan T. Leo,
Sr. VP of Operations -
Gina Hinman Trulli,
VP of HR -
Elizabeth Karpinski Vonne,
VP of Legal, Gen. Counsel & Sec. -
Robert Bradley,
Sr. Director of Operations -
Michael T Brooks,
Director -
H Stuart Campbell,
Director -
Ventures, Llc Seg,
Director -
Luke R Schmieder,
President CEO Treasurer -
Paul D Duke,
Director -
Michael Tranmer,
Executive Vice President -
Glenn E Adriance,
VP Sales and Marketing -
Steven W Peterson,
VP Finance, CFO, Secretary -
Robert V Dwyer,
Director -
David Brian Perez,
Director -
Mark Christopher Capone,
Director -
Shiraz Shabanali Ladiwala,
Director -
Laboratories Inc /Co/ Mesa,
Director -
R Tony Tripeny,
Director